2024
Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk.
Murnane P, Afshar M, Chamie G, Cook R, Ferguson T, Haque L, Jacobson K, Justice A, Kim T, Khalili M, Krupitsky E, McGinnis K, Molina P, Muyindike W, Myers B, Richards V, So-Armah K, Stewart S, Sulkowski M, Tien P, Hahn J. Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk. The American Journal Of Gastroenterology 2024 PMID: 39480054, DOI: 10.14309/ajg.0000000000003178.Peer-Reviewed Original ResearchLiver fibrosis riskAUDIT-CFIB-4Self-reported alcohol useOdds ratioAlcohol useFibrosis riskPooled individual-level dataLiver fibrosis preventionBody mass indexAssessment of alcohol useManagement of liver diseaseOne-unit differenceIndividual-level dataMedian ageAUDIT-C.Mass indexSuppression statusLiver diseaseFibrosis preventionBlood concentrationsAdjusted modelsLogistic regressionCategorical variablesHIVA Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System
Haque L, Tate J, Chew M, Caniglia E, Taddei T, Re V. A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System. Pharmacoepidemiology And Drug Safety 2024, 33: e70024. PMID: 39477692, DOI: 10.1002/pds.70024.Peer-Reviewed Original ResearchConceptsVeterans Health Administration dataHealth administrative dataAdministrative dataElectronic health record systemsHealth record systemsInternational Classification of DiseasesCoding algorithmOutpatient International Classification of DiseasesPositive predictive valueClassification of DiseasesHepatic decompensationDiagnosis codesPharmacoepidemiologic researchMedical recordsVeteransRecording systemValidation algorithmAlgorithmChronic liver diseaseDecompensationLiver diseasePredictive valueRecordsDiagnosisIntegrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.
Haque L, Leggio L. Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder. Hepatology 2024 PMID: 38935926, DOI: 10.1097/hep.0000000000000996.Peer-Reviewed Original ResearchAUD careAlcohol-associated liver diseaseAlcohol use disorderCollaborative careImpact of health disparitiesAlcohol-related deathsImpact of comorbid conditionsPublic health impactUse disorderHarm reduction approachesLiver diseaseInterprofessional teamHealth disparitiesTreatment of alcohol use disordersComprehensive careProblematic alcohol useSubstance use disordersSpectrum of alcohol-associated liver diseasesTreatment gapLiver-related outcomesMinority of patientsLiver-related morbidityAlcohol use disorder treatmentCareAlcohol useManagement of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities
Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque L, Balliet W, Serper M. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transplantation 2024, 30: 848-861. PMID: 38471008, DOI: 10.1097/lvt.0000000000000362.Peer-Reviewed Original ResearchAlcohol-associated liver diseaseAlcohol use disorderAUD careValue-based care modelsPrevalence of alcohol use disordersPost-LTLiver transplantationManagement of alcohol-associated liver diseasePost-transplant patient survivalLiver diseaseRisk of disease recurrenceUse disorderImprove patient outcomesPost-LT relapseCare modelSystemic barriersTherapy accessDigital healthUnmet needsLiver transplant candidatesAlcohol consumptionCenters of excellenceGlobal health burdenAddiction specialistsCareTreatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Haque L, Zuluaga P, Muga R, Fuster D. Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction Science & Clinical Practice 2024, 19: 19. PMID: 38504384, PMCID: PMC10949674, DOI: 10.1186/s13722-024-00448-8.Peer-Reviewed Original ResearchConceptsAlcohol-associated liver diseaseAlcohol use disorderLiver diseasePresence of liver cirrhosisTreatment of alcohol use disordersUse disorderInnovative treatment strategiesUnhealthy alcohol usePharmacologic treatment choicesTreating unhealthy alcohol useLiver transplantationLiver cirrhosisTreatment strategiesTreatment choiceEfficacious treatmentLiver deathsPatientsAlcohol useDiseaseLiverTreatmentDisordersCirrhosisTransplantation
2021
Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration
Haque L, Rosenheck R. Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration. Journal Of Public Mental Health 2021, 20: 191-200. DOI: 10.1108/jpmh-07-2020-0088.Peer-Reviewed Original ResearchVeterans Health AdministrationMental health treatmentSubstance use disordersSpecialized addiction treatmentLiver diseaseHealth treatmentAddiction treatmentMental healthHealth AdministrationUnited States Veterans Health AdministrationYears of ageDrug dependence diagnosesProportion of adultsService useUse disordersAlcohol dependenceDependence diagnosisDrug dependenceHomeless veteransVeteransTreatmentGood knowledgeComprehensive servicesHigh rateDisease
2020
Budd-Chiari Syndrome An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed
Haque LYK, Lim JK. Budd-Chiari Syndrome An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed. Clinics In Liver Disease 2020, 24: 453-481. PMID: 32620283, DOI: 10.1016/j.cld.2020.04.012.BooksConceptsBudd-Chiari syndromeLiver diseaseHepatic venous outflow obstructionPrimary Budd-Chiari syndromeDevelopment of cirrhosisVenous outflow obstructionChronic liver diseaseLife-threatening diagnosisVariable clinical presentationPortal hypertensionProthrombotic stateVenous obstructionLifelong anticoagulationMost patientsOutflow obstructionUncommon causeClinical presentationRare causeRisk factorsHepatocellular carcinomaHigh indexPatientsDiseaseSyndromeObstruction
2018
Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
McCarty TR, Echouffo-Tcheugui JB, Lange A, Haque L, Njei B. Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012. Surgery For Obesity And Related Diseases 2018, 14: 726. PMID: 29576483, DOI: 10.1016/j.soard.2018.02.020.Commentaries, Editorials and Letters
2017
Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
McCarty TR, Echouffo-Tcheugui JB, Lange A, Haque L, Njei B. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012. Surgery For Obesity And Related Diseases 2017, 14: 74-80. PMID: 29055669, DOI: 10.1016/j.soard.2017.09.511.Peer-Reviewed Original ResearchConceptsNonalcoholic fatty liver diseasePrior bariatric surgeryBariatric surgeryFatty liver diseaseIncidence risk ratioNAFLD patientsMorbid obesityRenal failureClinical outcomesLiver diseaseMyocardial infarctionRisk ratioNationwide Inpatient Sample AnalysisNationwide Inpatient Sample databaseObese NAFLD patientsOutcomes of patientsBariatric surgery proceduresMorbidly obese individualsPopulation-based dataHospital mortalityHospital morbidityInpatient mortalitySecondary outcomesHospitalized patientsPrimary outcome
2016
Impact of Bariatric Surgery on Outcomes of Patients with Non-alcoholic Fatty Liver Disease: A Nationwide Inpatient Sample (NIS) Analysis, 2004-2012
Njei B, McCarty T, Haque L, Echouffo-Tcheugui J. Impact of Bariatric Surgery on Outcomes of Patients with Non-alcoholic Fatty Liver Disease: A Nationwide Inpatient Sample (NIS) Analysis, 2004-2012. The American Journal Of Gastroenterology 2016, 111: s362-s363. DOI: 10.14309/00000434-201610001-00822.Peer-Reviewed Original Research